Porto Joao G, Arbelaez Maria Camila Suarez, Pena Brandon, Khandekar Archan, Malpani Ankur, Nahar Bruno, Punnen Sanoj, Ritch Chad R, Gonzalgo Mark L, Parekh Dipen J, Marcovich Robert, Shah Hemendra N
Desai Sethi Urology Institute, University of Miami, Miller School of Medicine, Miami, FL 33136, USA.
Stony Brook University Hospital, Stony Brook, NY 11794, USA.
Cancers (Basel). 2023 Oct 14;15(20):4984. doi: 10.3390/cancers15204984.
The microbiome, once considered peripheral, is emerging as a relevant player in the intricate web of factors contributing to cancer development and progression. These often overlooked microorganisms, in the context of urological malignancies, have been investigated primarily focusing on the gut microbiome, while exploration of urogenital microorganisms remains limited. Considering this, our systematic review delves into the complex role of these understudied actors in various neoplastic conditions, including prostate, bladder, kidney, penile, and testicular cancers. Our analysis found a total of 37 studies (prostate cancer 12, bladder cancer 20, kidney cancer 4, penile/testicular cancer 1), revealing distinct associations specific to each condition and hinting at potential therapeutic avenues and future biomarker discoveries. It becomes evident that further research is imperative to unravel the complexities of this domain and provide a more comprehensive understanding.
微生物群曾被认为处于边缘地位,如今在导致癌症发生和发展的复杂因素网络中,正逐渐成为一个重要角色。在泌尿生殖系统恶性肿瘤的背景下,这些常常被忽视的微生物主要是围绕肠道微生物群展开研究的,而对泌尿生殖系统微生物的探索仍然有限。鉴于此,我们的系统综述深入探讨了这些研究不足的因素在各种肿瘤疾病(包括前列腺癌、膀胱癌、肾癌、阴茎癌和睾丸癌)中的复杂作用。我们的分析共发现37项研究(前列腺癌12项、膀胱癌20项、肾癌4项、阴茎/睾丸癌1项),揭示了每种疾病特有的不同关联,并暗示了潜在的治疗途径和未来生物标志物的发现。显然,必须进一步开展研究,以阐明该领域的复杂性并提供更全面的理解。